대한암한의학회지 (Journal of Korean Traditional Oncology)

  • 제28권1호
  • /
  • Pages.11-24
  • /
  • 2023
  • /
  • 1975-244X(pISSN)
  • /
  • 2765-4850(eISSN)
대한암한의학회 (Korean Association of Traditional Oncology)
권호 표지
DOI QR코드

DOI QR Code

유방암 환자의 통함 암 치료를 통한 항암화학요법 유발 말초신경병증, 전신통 호전에 대한 증례 보고

A Case Report on Improvement of Chemotherapy-Induced Peripheral Neuropathy and Pantalgia Side Effects with Integrated Cancer Treatment in a Breast Cancer Patient

  • 김은지 (대전대학교 부속 천안한방병원 동서암센터) ;
  • 배혜리 (대전대학교 부속 천안한방병원 동서암센터) ;
  • 이남헌 (대전대학교 부속 천안한방병원 동서암센터)
  • Eun-Ji Kim (East-West Cancer Center, Cheonan Korean Medical Hospital, Daejeon University) ;
  • Hye-ri Bae (East-West Cancer Center, Cheonan Korean Medical Hospital, Daejeon University) ;
  • Nam-Hun Lee (East-West Cancer Center, Cheonan Korean Medical Hospital, Daejeon University)
  • 투고 : 2023.10.04
  • 심사 : 2023.12.03
  • 발행 : 2023.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: To report the improvement of chemotherapy-induced peripheral neuropathy and pantalgia with integrative cancer treatment on adverse effects of chemotherapy in a breast cancer patient. Methods: A 63-year-old female patient who has been diagnosed with breast cancer got treated for 103 days with integrative cancer treatment including acupuncture, moxibustion, herbal medicine, physiotherapies, hand and foot bath to decrease side effects of chemotherapy. The patient was also treated Western immunotherapies like Thymosin, Viscum album. Paclitaxel, Carboplatin, Doxorubicin, Cyclophosphamide was applied and chemotherapy-induced peripheral neuropathy(CIPN), pantalgia and nausea occured. The efficacy of treatment was measured by a numeric rating scale(NRS) of symptoms, National Cancer Institute Common Terminology Criteria for Adverse Event(NCI-CTCAE) and Eastern Cooperative Oncology Group(ECOG) Performance Status Scale. Results: The NRS scroes for CIPN, pantalgia, nausea were improved. There was no adverse effects of 3 or higher assessed by the NCI-CTCAE. The ECOG grade improved from grade 2 to 1. Conclusions: This study suggests that integrative cancer treatment could improve CIPN, pantalgia after chemotherapy in breast cancer.

키워드

과제정보

이 연구는 대한민국 정부(과학기술정보통신부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임(NRF-RS-2023-00246351)

참고문헌

  1. Ko EJ, Myeong JS, Kim JH, Park JH, Park SJ, Lee YY YH. A Case Report of Pancreatic Cancer with Liver Metastasis Patient Treated with Integrative Cancer Treatment. J Korean Tradit Oncol. 2021;26(1):39-48.
  2. Society KBC. A Case Report of Pancreatic Cancer with Liver Metastasis Patient Treated with Integrative Cancer Treatment.; 2022.
  3. Lee AB MB. Chemotherapy in Breast Cancer. Ewha Med J. 2014;37(2):75-82. https://doi.org/10.12771/emj.2014.37.2.75
  4. MY K. Transition of Symptoms and Quality of Life in Cancer Patients on Chemotherapy. J Korean Acad Nurs. 2009;39(3):433-445. https://doi.org/10.4040/jkan.2009.39.3.433
  5. Lee JR OP. A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients. J Korean Acad Nurs. 2019;49(4):375-385. https://doi.org/10.4040/jkan.2019.49.4.375
  6. Nikolaoua V, Syrigosa K SM. Incidence and implications of chemotherapy related hand-foot syndrome. Expert Opin Drug Saf. 2016;15(12):1625-1633. https://doi.org/10.1080/14740338.2016.1238067
  7. Choe YH, Kim SH, Oh HS, Seo WS LS. Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer: Associated Factors and Impact on Health-Related Quality of Life. Asian Oncol Nurs. 2020;20(2):83-91. https://doi.org/10.5388/aon.2020.20.2.83
  8. JE L. Chemotherapy for breast cancer patients Symptom experience by treatment course. Grad Sch Yonseo Univ. 2005:1-57.
  9. Song SY, Park JH, Lee JS, Kim JR, Sohn EH, Jung MS YH. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy. Integr Cancer Ther. 2020;19:1-12. https://doi.org/10.1158/1535-7163.1.19.1
  10. Han GJ, Lee AR, Jung JS, Seong S KS. A Case Study of a Patient with Breast Cancer Treated with a Combination of Traditional Korean Medicine and Chemotherapy. J Intern Korean Med. 2017;38(5):820-827. https://doi.org/10.22246/jikm.2017.38.5.820
  11. Kwon YK, Park JW, Lee JH, Yoo HS, Cho CK LY. Case Report of a Breast Cancer Patient Treated with Adriamycin/5-Fluriuracil Regimen in Combination with Traditional Korean Medicine for Mritigating Side Effects. J Intern Korean Med. 2011;32(4):610-615.
  12. Lee C, Cho IH, Heo GY, Kang HK, Kim MH, Han CW, Kim SY, Choi JY, Park SH, Yun YJ, Hong JW, Kwon JN LI. Analysis of the Numeric Rating Scale (NRS) Used in Clinical Studies Based on Randomized Controlled Studies. J Int Korean Med. 2021;42(4):510-531. https://doi.org/10.22246/jikm.2021.42.4.510
  13. U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.; 2017.
  14. Yeum JY, Kim SH, Oh SY PS. Korean Medicine Treatments with Joripewon-tang for Chemotherapy-Induced Peripheral Neuropathy of Ovarian Cancer : Case Report. J Korean Tradit Oncol. 2022;27(1):49=56.
  15. Chien TJ, Liu CY, Fang CJ KC. The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis. Integr Cancer Ther. 2019;18:1-10. https://doi.org/10.1177/1534735419886662
  16. Joo HE, Park JH, Song SY, Cho YM, Park SJ YH. A Case Report of Traditional Korean Medicine-Based Integrative Oncology of Recurrent Cervical Cancer. J Intern Korean Med. 2022;43(4):751-760. https://doi.org/10.22246/jikm.2022.43.4.751
  17. Yeom JY, Ahn SB, Park SJ OS. Korean Medicine-based Integrative Oncology Therapies on adverse effects of Chemotherapy in Non-Small Cell Lung Cancer : 2 Case. J Korean Tradit Oncol. 2022;27(1):57-66.
  18. Lee J, Park IB SH. Pain-related Prescribing Patterns and Associated Factor in Breast Cancer Patients. Korean J Clin Pharm. 2021;31(2):115-124. https://doi.org/10.24304/kjcp.2021.31.2.115
  19. ML Z. A Taxing Consequence : Taxane Acute Pain Syndrome. J Hematol Oncol Pharm. 2017;7(2):80-83.
  20. Lee HS, Kim GM, Sohn JH, Kim SM SH. Occurrence of Taxane Induced Acute Pain Syndrome in Patient with Breast Cancer : A Preliminary Study. J Pain Auton Disord. 2014;3(2):83-87.
  21. Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MFK, Jacobs C, Ong M CM. Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review. Support Care Cancer. 2016;24(8):3633-3650. https://doi.org/10.1007/s00520-016-3256-5
  22. Park HS, Lee DE, Ha JS, Seo HS KJ. Bibliometric Analysis of the Effect of Acupunture on Cancer Pain in the Last 20 Years. J Intern Korean Med. 2021;42(3):279-292. https://doi.org/10.22246/jikm.2021.42.3.279
  23. Lee JS YS. Efficacy and safety of moxibustion for relieving pain in patients with metastatic cancer: A pilot, randomized, single-blind, sham-controlled trial. Integr Cancer Ther. 2014;13(3):211-216. https://doi.org/10.1177/1534735413510025
  24. Nam DJ, Oh MS. Review about the Study of Ssanghwa-tang Published in Korea from 2000 to 2019. J of Haehwa Med. 2019;28(2):12-19.
  25. Jung JT. Management of Gastrointestinal Side Effect During Chemotherapy. Journal of Digestive Cancer Reports. 2015;3(2):76-81. https://doi.org/10.21608/secioj.2015.5701
  26. National Institute for Korean Medicine Development. Clinical practice guideline of korean medicine. 2021. p.1-202